Literature DB >> 19467213

The DeMSTification of mammalian Ste20 kinases.

Maria Radu1, Jonathan Chernoff.   

Abstract

When first reported in 1995, the mammalian Ste20-like kinases (Mst) 1 and 2 were so named both for their similarity to the yeast kinase Ste20 and for the fact that their function was, to us, a deep mystery. While much remains to be explained about the regulation and role of these kinases, the veil has been at least partly raised on the Msts, revealing unexpected modes of activation and function. Work in model organisms suggests a central growth-suppressive role for Mst orthologs, with intriguing possible links to other established tumor suppressors. This minireview underlines our current understanding of how Mst1 and Mst2 are regulated, and how activation of these proteins influences cell survival and proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19467213     DOI: 10.1016/j.cub.2009.04.022

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  30 in total

1.  Dimerization and cytoplasmic localization regulate Hippo kinase signaling activity in organ size control.

Authors:  Yunyun Jin; Liang Dong; Yi Lu; Wenqing Wu; Qian Hao; Zhaocai Zhou; Jin Jiang; Yun Zhao; Lei Zhang
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

2.  YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy.

Authors:  Alexander von Gise; Zhiqiang Lin; Karin Schlegelmilch; Leah B Honor; Gina M Pan; Jessica N Buck; Qing Ma; Takahiro Ishiwata; Bin Zhou; Fernando D Camargo; William T Pu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice.

Authors:  Dominic P Del Re; Takahisa Matsuda; Peiyong Zhai; Shumin Gao; Geoffrey J Clark; Louise Van Der Weyden; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

Review 4.  MST1: a promising therapeutic target to restore functional beta cell mass in diabetes.

Authors:  Amin Ardestani; Kathrin Maedler
Journal:  Diabetologia       Date:  2016-04-06       Impact factor: 10.122

5.  Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling.

Authors:  Hee Jae Yun; Je-Hyun Yoon; Jae Keun Lee; Kyung-Tae Noh; Kyoung-Wan Yoon; Sang Phil Oh; Hyun Jung Oh; Ji Soo Chae; Sang Gil Hwang; Eun Hee Kim; Gerd G Maul; Dae-Sik Lim; Eui-Ju Choi
Journal:  EMBO J       Date:  2011-05-13       Impact factor: 11.598

6.  Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.

Authors:  Howard Donninger; Nadia Allen; Adrianna Henson; Jennifer Pogue; Andrew Williams; Laura Gordon; Susannah Kassler; Thomas Dunwell; Farida Latif; Geoffrey J Clark
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

Review 7.  Regulation of Foxo-dependent transcription by post-translational modifications.

Authors:  Marco Boccitto; Robert G Kalb
Journal:  Curr Drug Targets       Date:  2011-08       Impact factor: 3.465

8.  Mammalian Ste20-like kinase (Mst2) indirectly supports Raf-1/ERK pathway activity via maintenance of protein phosphatase-2A catalytic subunit levels and consequent suppression of inhibitory Raf-1 phosphorylation.

Authors:  Geoffrey K Kilili; John M Kyriakis
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

9.  Crystal structure and putative substrate identification for the Entamoeba histolytica low molecular weight tyrosine phosphatase.

Authors:  Alicia S Linford; Nona M Jiang; Thomas E Edwards; Nicholas E Sherman; Wesley C Van Voorhis; Lance J Stewart; Peter J Myler; Bart L Staker; William A Petri
Journal:  Mol Biochem Parasitol       Date:  2014-02-15       Impact factor: 1.759

10.  The germinal center kinase GCK-1 is a negative regulator of MAP kinase activation and apoptosis in the C. elegans germline.

Authors:  Katherine R Schouest; Yasuhiro Kurasawa; Tokiko Furuta; Naoki Hisamoto; Kunihiro Matsumoto; Jill M Schumacher
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.